Adenosine A2A receptor agonist polydeoxyribonucleotide ameliorates short-term memory impairment by suppressing cerebral ischemia-induced inflammation via MAPK pathway
Open Access
- 18 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0248689
Abstract
Cerebral ischemia causes tissue death owing to occlusion of the cerebral blood vessels, and cerebral ischemia activates mitogen-activated protein kinase (MAPK) and induces secretion of pro-inflammatory cytokines. Adenosine A2Areceptor agonist, polydeoxyribonucleotide (PDRN), suppresses the secretion of pro-inflammatory cytokines and exhibits anti-inflammatory effect. In the current study, the therapeutic effect of PDRN on cerebral ischemia was evaluated using gerbils. For the induction of cerebral ischemia, the common carotid arteries were exposed, and then aneurysm clips were used to occlude the common carotid arteries bilaterally for 7 minutes. In the PDRN-treated groups, the gerbils were injected intraperitoneally with 0.3 mL of saline containing 8 mg/kg PDRN, per a day for 7 days following cerebral ischemia induction. In order to confirm the participation of the adenosine A2Areceptor in the effects mediated by PDRN, 8 mg/kg 7-dimethyl-1-propargylxanthine (DMPX), adenosine A2Areceptor antagonist, was treated with PDRN. In the current study, induction of ischemia enhanced the levels of pro-inflammatory cytokines and increased phosphorylation of MAPK signaling factors in the hippocampus and basolateral amygdala. However, treatment with PDRN ameliorated short-term memory impairment by suppressing the production of pro-inflammatory cytokines and inactivation of MAPK signaling factors in cerebral ischemia. Furthermore, PDRN treatment enhanced the concentration of cyclic adenosine-3,5’-monophosphate (cAMP) as well as phosphorylation of cAMP response element-binding protein (p-CREB). Co-treatment of DMPX and PDRN attenuated the therapeutic effect of PDRN on cerebral ischemia. Based on these findings, PDRN may be developed as the primary treatment in cerebral ischemia.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1D1A1B03032827)
This publication has 43 references indexed in Scilit:
- Neuroprotective effect of olive oil in the hippocampus CA1 neurons following ischemia: Reperfusion in miceJournal of Neurosciences in Rural Practice, 2013
- Inflammatory Cytokines in Experimental and Human StrokeJournal of Cerebral Blood Flow & Metabolism, 2012
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year UpdatePhysiological Reviews, 2012
- Injury-induced activation of the MAPK/CREB pathway triggers apoptosis-induced compensatory proliferation in hydra head regenerationDevelopment, Growth & Differentiation, 2011
- Inflammation After Stroke: Mechanisms and Therapeutic ApproachesTranslational Stroke Research, 2010
- Inflammatory and Neuroimmunomodulatory Changes in Acute Cerebral IschemiaCerebrovascular Diseases, 2009
- Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosineNeuropharmacology, 2008
- Adenosine A2A receptors are required for normal BDNF levels and BDNF‐induced potentiation of synaptic transmission in the mouse hippocampusJournal of Neurochemistry, 2007
- Aggravated Brain Damage After Hypoxic Ischemia in Immature Adenosine A 2A Knockout MiceStroke, 2003
- More hippocampal neurons in adult mice living in an enriched environmentNature, 1997